Dynamic Chemotherapy Drug Permeation Testing

Ansell’s Cytostatic Permeation Program (ACPP) is a unique dynamic permeation test designed to give healthcare professionals working with hazardous drugs a perspective of how working conditions may influence the permeation of your glove’s protective barrier. ACPP gives you an added confidence advantage as current ASTM¹ and EN² standards testing are static and do not reflect the impact glove properties such as thickness; the stretching and flexing motion of the task, as well as both body and workplace temperatures will have on permeation of chemo tested gloves. ^3,4,5,6

What’s the difference between ASTM & EN standards testing and ACPP?

ASTM and EN chemotherapy standards testing are often mandatory and must always be available as your guide. ACPP testing gives you an in-use perspective to make the right glove choice for safer handling of chemotherapy drugs. Unlike standards, ACPP mimics everyday use in the workplace through controlled dynamic conditions. 

THE ADVANTAGE OF DYNAMIC PERMEATION TESTING

Minimizing your risk of exposure to hazardous drugs starts by using all available permeation data. Having both Standards and ACPP permeation results available is an advantage to help you choose the right glove.

HOW ACPP WORKS

Ansell is the only glove manufacturer with its own dynamic permeation testing method and device. Watch ACPP in action.

THE ACPP ADVANTAGE

Download our ACPP brochure for a detailed understanding of how ACPP complements Standards, clinical evidence and results summary.